And Res synergically inhibit SphK1 activity, through a novel ERK/PLD-dependent mechanism in prostate cancer cells
And Res synergically inhibit SphK1 activity, through a novel ERK/PLD-dependent mechanism in prostate cancer cells (C4-2B hormone-responsive and PC-3 hormone- refractory) acting as a possible anti-cancer effector . According to…